Weixue Huang

机构：Chinese Academy of Sciences, Shanghai Institute of Organic Chemistry · ORCID：0000-0003-4884-6585

发表论文 45 篇 · 总被引 884 次 · h-index 18

代表论文

Neuronal K+-Cl- cotransporter KCC2 as a promising drug target for epilepsy treatment (2023 · Acta Pharmacologica Sinica · 被引 74)
Discovery of LWY713 as a potent and selective FLT3 PROTAC degrader with in vivo activity against acute myeloid leukemia (2023 · European Journal of Medicinal Chemistry · 被引 23)
Discovery of LLC0424 as a Potent and Selective in Vivo NSD2 PROTAC Degrader (2024 · Journal of Medicinal Chemistry · 被引 22)
Discovery of a First-in-Class Degrader for the Lipid Kinase PIKfyve (2023 · Journal of Medicinal Chemistry · 被引 22)
Structure-Based Design of “Head-to-Tail” Macrocyclic PROTACs (2024 · JACS Au · 被引 20)
Discovery of ZLC491 as a Potent, Selective, and Orally Bioavailable CDK12/13 PROTAC Degrader (2024 · Journal of Medicinal Chemistry · 被引 20)